Xeloda var mindst ækvivalent med 5- FU/ LV i. v. mht. sygdomsfri overlevelse i protokolpopulationen (hazard ratio 0, 92; 95% konfidensinterval 0, 80- 1, 06).
Xeloda was at least equivalent to IV 5-FU/ LV in disease-free survival in per protocol population (hazard ratio 0.92; 95% CI 0.80- 1.06).